Compass Wealth Management LLC

Position in NVS — Novartis AG

CIK 1965653 GUILFORD, CT

Position in NVS

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,997,709

+$35,330 QoQ

Shares Held

12,747

-0.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#433

of 1,603 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Compass Wealth Management LLC holds $18,364,693 across 8 Drug Manufacturers - General names. NVS ranks #3 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,093	$7,308,127
2	ABBV	AbbVie Inc.	25,828	$6,499,357
3	NVS	Novartis AG This page	12,747	$1,997,709
4	JNJ	Johnson & Johnson	3,985	$1,012,070
5	MRK	Merck & Co., Inc.	6,487	$833,579
6	BMY	Bristol Myers Squibb Co	5,648	$325,437
7	AMGN	Amgen Inc	775	$280,643
8	GRFS	Grifols SA	15,222	$107,771

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,997,709	12,747	-0.8%	Shares	Sole	2026-08-10
2026-03-31	$1,962,379	12,847	-0.8%	Shares	Sole	2026-04-21
2025-12-31	$1,785,002	12,947	-1.9%	Shares	Sole	2026-02-11
2025-09-30	$1,692,383	13,197	-0.9%	Shares	Sole	2025-11-07
2025-06-30	$1,612,095	13,322	-6.2%	Shares	Sole	2025-08-08
2025-03-31	$1,583,016	14,200	-5.3%	Shares	Sole	2025-04-29
2024-12-31	$1,459,650	15,000	-9.8%	Shares	Sole	2025-01-21
2024-09-30	$1,912,207	16,625	-5.4%	Shares	Sole	2024-10-16
2024-06-30	$1,871,034	17,575	-0.3%	Shares	Sole	2024-07-16
2024-03-31	$1,704,866	17,625	-3.6%	Shares	Sole	2024-04-05
2023-12-31	$1,846,236	18,285	+2.4%	Shares	Sole	2024-01-04
2023-09-30	$1,818,201	17,850	-1.9%	Shares	Sole	2023-10-25
2023-06-30	$1,836,562	18,200	-0.8%	Shares	Sole	2023-07-27
2023-03-31	$1,688,200	18,350	0.0%	Shares	Sole	2023-05-15
2022-12-31	$1,664,712	18,350	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.